Vivani Medical, Inc. (VANI)

Every figure this model derived for VANI, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 1,199,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 27,129,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 21,635,000 AssetsCurrent 2026-06-30
current liabilities 6,659,000 LiabilitiesCurrent 2026-06-30
equity 18,967,000 StockholdersEquity 2026-06-30
ocf -25,301,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 0 RevenueFromContractWithCustomerIncludingAssessedTax 2025-12-31
sbc 1,368,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up VANI on one particular measure came for.

RatioValue
current ratio3.25
current ratio reported3.25
deferred revenue growth0.0
dilution pct13.48

What to be careful about

What this model itself distrusts about VANI's figures. Written by the derivation as it ran, not added afterwards.